In the past 10 years, auto inflammatory diseases have gained recognition as a distinct class of disorders that are characterized by recurrent episodes of systemic inflammation resulting in fevers, leukocyte-mediated tissue infiltration, and dysregulated cytokine production. The recent discovery of genetic determinants of this spectrum of disorders has resulted in new insights into these diseases. Unlike autoimmune diseases, autoinflammatory diseases are marked by the notable absences of autoantibodies or the critical role of self-reactive B and T lymphocytes.
Pyrin, cryopyrin, ASC, and NOD2 share structural domains common to molecules involved in inflammatory pathways.21,23,26,37 The pyrin domain is a member of the 6-helix bundle DD-fold superfamily. The NACHT domain contains a highly-conserved nucleotide-binding sequence. Abbreviation expansions are provided in the box at the end of this article.
Models: cryopyrin and pyrin associate with ASC to stimulate NFκB activation (A) and IL-1β cytokine processing (B), respectively. A, Association between cryopyrin and ASC activates the NFκB pathway. Pyrin inhibits activation of the NFκB pathway by disrupting the association between ASC and cryopyrin. Stimuli derived from pathogens may activate cryopyrin and/or pyrin. Mutations in cryopyrin or pyrin may lead to increased NFκB activation, resulting in dysregulated cytokine production, apoptosis, and inflammation. B, The ASC mediates activation of caspase 1, the IL-1β converting enzyme.26,35,39 Caspase 1 is required to generate active IL-1 from its precursor form (pro-IL-1β), which is initially produced by activated macrophages and monocytes. Together with additional caspases, pyrin, ASC, and caspase 1 may associate to form a signaling complex termed the “inflammasome.”26,40,41 Cryopyrin may associate with ASC and pyrin. Mutations in pyrin may lead to autoinflammatory disease by failing to regulate caspase-1 activity, resulting in increased cytokine production and inflammation. Abbreviation expansions are provided in the box at the end of this article.
Thank you for submitting a comment on this article. It will be reviewed by JAMA Dermatology editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 17
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
The Rational Clinical Examination
The Rational Clinical Examination
All results at
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.